Apolipoprotein B / Apolipoprotein A-I Ratio a better Diagnostic Marker of Coronary Heart Disease than Conventional LDL/HDL Ratio

Journal Title: National Journal of Laboratory Medicine - Year 2016, Vol 5, Issue 3

Abstract

Introduction: Apolipoprotein B (Apo B) and apolipoprotein A-I (Apo-I) are cholesterol transporters playing an important role in lipid metabolism. Apo B and A-I represent the total atherogenic and non-atherogenic particles respectively. Hence, their ratio – Apo B/A-I has been strongly associated with various cardiovascular events. Aim: To compare the diagnostic efficacy of apolipoproteins with conventional lipids for coronary heart disease. Materials and Methods: There were 295 individuals with or without coronary heart disease were enrolled in the study. The demographic details along with clinical investigations of serum lipid parameters, Apo B and Apo A-I levels were obtained and recorded. Study Design: It was a single centre, prospective observational study of 295 individuals of both the genders (235 males and 60 females) with or without coronary artery disease. Statistical Analysis: A comparison of parametric values between two groups was performed using student’s t-test. Non-parametric analysis of the continuous data was performed using Mann-Whitney U test. Significance was taken as two tailed p<0.05. Results: In study population, 221(74.92%) had coronary heart disease (CHD) and 74(25.08%) were normal. Statistically significant differences were found in the levels of apo B/apo A-I ratio (p=0.009), and Apo A-I (p≤0.001) between two groups. The other lipid parameters and ratios such as cholesterol, triglyceride, HDL-C, LDL-C, nonHDL-C cholesterol, VLDL, Total lipid, Apo-B, LDL-C/HDL-C and TC/HDL-C were not found to be significant. Conclusion: The present study shows that Apo B/A-I possesses superior diagnostic efficacy for coronary heart disease as compared to conventional lipid parameters and could be effectively used in clinical practice.

Authors and Affiliations

Dr. Jayesh S. Prajapati, Dr. Jagjeet K. Deshmukh, Dr. Krutika H. Patel, Dr. Komal H. Shah, Dr. Hasit J. Joshi, Dr. Ranajeet More, Dr. Sibasis S. Sahoo

Keywords

Related Articles

Laboratory and Etiological Profile of Febrile Thrombocytopenia Cases- A Cross Sectional Study

Introduction: Fever is a symptom which is caused by a variety of illnesses and it usually occurs in response to an infection or inflammation. Patients presenting with fever in tropical country like India usually have an...

Alterations of Serum Transaminases in HIV patients on ART

Introduction: Elevation of liver enzymes is a sensitive signal of drug induced liver injury in HIV patients receiving Antiretroviral Therapy (ART). Studies reporting severe hepatotoxicity due to the administration of ART...

Uterine Adenomyosis in Mullerian Remnant with Transverse Vaginal Septum with Haematocolpos in Mayer-Rokitansky-Kuster-Hauser Syndrome: A Case Report

The Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome is a rare disorder characterised by failure of the uterus and vagina to develop properly in women who have normal ovarian function and normal external genitalia and seco...

Antibiogram Study of Clinical Isolates of Enterococcus in a Tertiary Care Teaching Hospital

Introduction: Excessive and non-specific use of broadspectrum antibiotics has converted Enterococci from a normal gut commensal to opportunistic nosocomial as well as community acquired pathogen. The high level resistanc...

Predictive Role of Fasting and PostPrandial Glucose towards Glycemic Control

Introduction: In the absence of glycated hemoglobin (HbA1c) estimation, particularly in rural set up in most developing countries, the overall metabolic control may be predicted by evaluating fasting and postprandial pla...

Download PDF file
  • EP ID EP380014
  • DOI 10.7860/NJLM/2016/17706:2130
  • Views 117
  • Downloads 0

How To Cite

Dr. Jayesh S. Prajapati, Dr. Jagjeet K. Deshmukh, Dr. Krutika H. Patel, Dr. Komal H. Shah, Dr. Hasit J. Joshi, Dr. Ranajeet More, Dr. Sibasis S. Sahoo (2016). Apolipoprotein B / Apolipoprotein A-I Ratio a better Diagnostic Marker of Coronary Heart Disease than Conventional LDL/HDL Ratio. National Journal of Laboratory Medicine, 5(3), 1-5. https://europub.co.uk./articles/-A-380014